|
42058833 |
0 |
Mai V, Martens ESL, Righini M, et al.
Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism.
Res Pract Thromb Haemost. 2026 Mar 25;10(3):103442. doi: 10.1016/j.rpth.2026.103442. eCollection 2026 Mar.
|
|
40578691 |
0 |
Mai V, Martens ESL, Righini M, et al.
Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study.
J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019.
|
|
40327961 |
0 |
Brown C, Mallick R, Pecarskie A, et al.
Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapy.
Thromb Res. 2025 Apr 30;250:109335. doi: 10.1016/j.thromres.2025.109335.
|
|
39197347 |
0 |
Wang TF, Mallick R, Noureldin A, et al.
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
Thromb Res. 2024 Oct;242:109123. doi: 10.1016/j.thromres.2024.109123. Epub 2024 Aug 20.
|
|
36100263 |
0 |
Auer RC, Ott M, Karanicolas P, et al.
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial.
BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375.
|
|
34807722 |
0 |
Le Gal G, Kovacs MJ, Bertoletti L, et al.
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
Ann Intern Med. 2022 Jan;175(1):29-35. doi: 10.7326/M21-2981. Epub 2021 Nov 23.
|